With new funding from the Falk Medical Trust, Professor Seungpyo Hong and Allan Brasier, executive director of the UW Institute for Clinical and Translational Research, are paving the way for a novel treatment for idiopathic pulmonary fibrosis.

With new funding from the Falk Medical Trust, Professor Seungpyo Hong and Allan Brasier, executive director of the UW Institute for Clinical and Translational Research, are paving the way for a novel treatment for idiopathic pulmonary fibrosis.
An award-winning paper from School of Pharmacy researchers highlights and influences the decision-making process for older adults selecting over-the-counter medications.
School of Pharmacy Professor Jeffrey Johnson and his collaborators uncover a potential therapy for Alzheimer’s in a study published in Nature Communications By Eric Hamilton This article originally appeared on UW–Madison’s news page. Increasing the expression of one …
Through a string of NIH grants, Assistant Professor Jay Ford advances critical research to improve access to medication-assisted therapy for opioid use disorder.
Alum Mohamed Amin (PhD ’13) empowers clinicians and patients with culturally relevant care.
Alum Rattavut Teerakapibal (PhD ’18) uses his passion and wealth of technical knowledge for formulation and process development to improve HIV therapies.
Assistant Professor Quanyin Hu and his CIPT Lab team addresses one of the biggest limitations of treating disease with probiotics By Eric Hamilton This article originally appeared on UW–Madison’s news page. Scientists studying probiotics, beneficial bacteria that show …
In the 2020–21 Fiscal Year, School of Pharmacy researchers received six patents to improve drug delivery and discovery.
School of Pharmacy alum Lucas Schulz improves antibiotic usage and prescribing at UW Health to tackle antimicrobial resistance.
As psychoactive substances gain therapeutic evidence, Assistant Professor Cody Wenthur aims to reverse underrepresentation of minorities in clinical studies.